Bioavailability Study of Fexofenadine HCl New Formulation Tablet

Clinical trial NCT06284902 · COMPLETED

Trial details

NCT number: NCT06284902
Sponsor: Opella Healthcare Group SAS, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-02-23
Primary completion: 2024-05-08
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.